We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
+10.51%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$104M
AUM Growth
+$8.55M
Cap. Flow
+$7.51M
Cap. Flow %
7.22%
Top 10 Hldgs %
35.65%
Holding
124
New
22
Increased
30
Reduced
40
Closed
12

Top Buys

Rank Stock Value
1
TEAR
TearLab Corporation
TEAR
+$1.85M
2
FLXN
Flexion Therapeutics, Inc.
FLXN
+$1.31M
3
TGT icon
Target
TGT
+$1.13M
4
REI icon
Ring Energy
REI
+$1.03M
5
TCMD icon
Tactile Systems Technology
TCMD
+$979K

Top Sells

Rank Stock Value
1
AXGN icon
Axogen
AXGN
+$1.07M
2
ENTL
Entellus Medical, Inc. Common Stock
ENTL
+$1.05M
3
ZAGG
ZAGG Inc Common Stock (Delaware)
ZAGG
+$1.05M
4
COR icon
Cencora
COR
+$976K
5
CYRX icon
CryoPort
CYRX
+$602K

Sector Composition

Rank Sector Weight
1 Healthcare 59.08%
2 Technology 10.55%
3 Industrials 9.42%
4 Financials 4.89%
5 Consumer Staples 3.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MMAT
101
DELISTED
Meta Materials Inc. Common Stock
MMAT
$96K 0.09%
358
-30
-8% -$7.42K
USAU icon
102
US Gold Corp
USAU
$220M
$95K 0.09%
+5,800
New +$84.6K
ALT icon
103
Altimmune
ALT
$587M
$71K 0.07%
1,182
-478
-29% -$30.5K
BLFS icon
104
BioLife Solutions
BLFS
$1.54B
$66K 0.06%
11,000
-4,000
-27% -$23.1K
JYNT icon
105
The Joint Corp
JYNT
$121M
$62K 0.06%
+12,500
New +$62.1K
PLM
106
DELISTED
PolyMet Mining Corp.
PLM
$61K 0.06%
7,113
– –
LIQT icon
107
LiqTech
LIQT
$20.6M
$57K 0.05%
3,125
-430
-12% -$5.48K
AIFC
108
AI Financial Corp
AIFC
$52.1M
$52K 0.05%
10,000
– –
BKYI
109
BIO-key International
BKYI
$4.62M
$44K 0.04%
17
-47
-73% -$132K
AIRI icon
110
Air Industries Group
AIRI
$13.2M
$27K 0.03%
1,600
– –
DGLT
111
DELISTED
Digiliti Money Group, Inc. Common Stock
DGLT
$3K ﹤0.01%
27,778
– –
AMD icon
112
Advanced Micro Devices
AMD
$737B
– –
-17,500
Closed -$223K
BSX icon
113
Boston Scientific
BSX
$69.2B
– –
-7,000
Closed -$204K
COR icon
114
Cencora
COR
$62.2B
– –
-11,800
Closed -$976K
GSK icon
115
GSK
GSK
$106B
– –
-9,520
Closed -$483K
NUWE icon
116
Nuwellis
NUWE
$175K
– –
0
– -$59K
VCYT icon
117
Veracyte
VCYT
$4.53B
– –
-62,275
Closed -$546K
OPGN
118
DELISTED
OpGen, Inc
OPGN
– –
-14
Closed -$434K
CTG
119
DELISTED
Computer Task Group, Inc.
CTG
– –
-45,500
Closed -$244K
GWGH
120
DELISTED
GWG Holdings, Inc
GWGH
– –
-10,400
Closed -$105K
ZAGG
121
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
– –
-66,700
Closed -$1.05M
YUMA
122
DELISTED
Yuma Energy Inc
YUMA
– –
-10,000
Closed -$143K
ENTL
123
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
– –
-57,150
Closed -$1.05M
DXTR
124
DELISTED
Dextera Surgical Inc.
DXTR
– –
-150,650
Closed -$42K
1 2 3 4
5

Similar funds

SVP
Strategic Value Partners Greenwich, Connecticut $133M AUM
PWP
Phillips Wealth Planners Starkville, Mississippi $133M AUM 20.41% 1-Year Est. Return
BF
Bonfire Financial Colorado Springs, Colorado $133M AUM 12.09% 1-Year Est. Return
SFG
Synergy Financial Group San Ramon, California $133M AUM 22.16% 1-Year Est. Return
HWMG
Harbour Wealth Management Group Daniel Island, South Carolina $133M AUM
CAG
Centerpoint Advisory Group Overland Park, Kansas $133M AUM 19.82% 1-Year Est. Return
FTEA
Forty-three Eighteen Advisors Bentonville, Arkansas $133M AUM
WT
WHI Trust Chicago, Illinois $133M AUM

Perkins Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Perkins Capital Management held 124 positions worth $104M, up 9% from $95.4M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Perkins Capital Management deployed $7.51M of net new capital in Q4 2017, opening 22 new positions and adding to 30 existing holdings. Its largest new stake was Flexion Therapeutics, Inc.: 53,500 shares worth $1.34M.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, down from 64% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Axogen, an estimated $1.07M trimmed.

  • Perkins Capital Management's largest Q4 2017 buy was Flexion Therapeutics, Inc.: 53,500 shares worth $1.34M.
  • Perkins Capital Management added most to TearLab Corporation in Q4 2017, an estimated $1.85M increase.
  • Perkins Capital Management's biggest Q4 2017 reduction was Axogen, cutting an estimated $1.07M.
  • Perkins Capital Management fully exited Entellus Medical, Inc. Common Stock in Q4 2017, selling an estimated $1.05M.
  • Perkins Capital Management's ten largest holdings make up 36% of its $104M portfolio in Q4 2017.
  • Perkins Capital Management opened 22 new positions and closed 12 in Q4 2017.
  • Perkins Capital Management's portfolio value rose 9% quarter-over-quarter to $104M.

Based on Perkins Capital Management's 13F filing for Q4 2017, filed 26 Jan 2018.